Marta Kaluzna Oleksy

Interventional cardiologist / Cardiologist
Poznan University of Medical Sciences - Poznan, Poland

Latest contributions

Integration of CT and IVUS for treatment of coronary artery disease in daily practice: from planning to drug-eluting therapy

22 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session highlights how imaging can drive precision in modern PCI. From CT-guided planning to IVUS-guided drug-eluting balloon interventions, each presentation offers practical insights into optimising patient outcomes. Step-by-step approaches and recorded cases illustrate how to tailor tool and technique selection, while also addressing...

Integration of CT and IVUS for treatment of coronary artery disease in daily practice: from planning to drug-eluting therapy

Integrating CT coronary angiography into your PCI practice

22 May 2025 – From EuroPCR 2025

Integrate CT coronary angiography into your PCI practice to enhance procedural planning and outcomes. This session covers practical CT-based approaches for guiding catheter selection, lesion analysis, and stenting strategy. Learn how to leverage CT imaging to anticipate plaque preparation needs in calcified lesions and optimize catheterization...

Integrating CT coronary angiography into your PCI practice

Non-antiplatelet drugs interventionalists should be aware of

21 May 2025 – From EuroPCR 2025

Gain essential knowledge on non-antiplatelet drugs relevant to interventional cardiology. Topics include the effects of empagliflozin on oxidative stress, the impact of midazolam on radial spasm during primary PCI, pharmacological cocktails to prevent radial spasm, and hydration strategies in patients with kidney disease during cardiac catheterisation.

Non-antiplatelet drugs interventionalists should be aware of

Chronic coronary syndrome with low ejection fraction and left ventricle support

21 May 2025 – From EuroPCR 2025

This session examines the management of chronic coronary syndrome in patients with low ejection fraction, emphasizing the role of left ventricular support. Topics include risks of intracoronary imaging, pharmacological facilitation, mechanical circulatory support, and alternatives like LAVA-ECMO.

Chronic coronary syndrome with low ejection fraction and left ventricle support

Antithrombotic drugs for acute coronary syndromes in women

21 May 2025 – From EuroPCR 2025

Enhance your understanding of antithrombotic drug management in women with acute coronary syndromes (ACS). This session addresses risk stratification balancing ischemic and bleeding risks, evidence-based tailored antithrombotic and revascularisation strategies in high bleeding risk patients, and diagnostic and treatment approaches for MINOCA, with illustrative cases highlighting...

Antithrombotic drugs for acute coronary syndromes in women

DCB in challenging scenarios - Part 2

20 May 2025 – From EuroPCR 2025

Explore the application of drug-coated balloons (DCB) in challenging coronary scenarios with a focus on recurrent calcified stenosis, in-stent restenosis, and left main interventions. This session includes case discussions on plaque phenotype-guided DCB treatment, 'leave nothing behind' strategy, and complex left main PCI using kissing DCBs...

DCB in challenging scenarios - Part 2

Troubleshooting in left main stenting: the role of imaging and physiology

20 May 2025 – From EuroPCR 2025

Expand your expertise on left main stenting by integrating intravascular imaging and physiology to improve outcomes. This session focuses on avoiding and managing stent deformation and optimal treatment of ostial left circumflex artery after crossover stenting, illustrated by clinical cases and expert commentary.

Troubleshooting in left main stenting: the role of imaging and physiology